semaglutide intracranial hypertension Management of IIH. The treatment of IIH focuses on vision preservation GLP-1 medications and pseudotumor cerebri

Research shows a 40-fold increase in these drugs from 2017 to 2021, estimating that roughly 2-3% of the United States is now on either Ozempic or Mounjaro

FDA have yet to make statements of their own, as far as I can tell, though I suspect they are coming

commercial health claims data covering over 50 million insured individuals - including 139,000 GLP-1 users from 2022 to 2024 - our findings reveal powerful insights: Cost Savings:In their second year, GLP-1 users showed a 7% improvement in the growth of medical spend - a strong indicator of potential long-term savings for employers

We break down MEDVipricing, refunds, pharmacy qualityand compare it to Remedy Meds & Josie

Figure 3 shows at a high level how each country can be mapped against indicators of their ability for public reimbursement (GDP per capita) and private spend (out-of-pocket [OOP] expenditure per capita) with the size of the bubble proportional to total 2025 list-price semaglutide sales